AdvisorNet Financial Inc trimmed its position in shares of Quest Diagnostics Incorporated () by 13.7% during the 3rd quarter, reports.

Source: https://www.americanbankingnews.com/2023/12/25/advisornet-financial-inc-sells-122-shares-of-quest-diagnostics-incorporated-nysedgx.html

Apple Diagnostics also provides detailed information about detected issues so you can take the appropriate steps to resolve them.

Source: https://www.devicemag.com/how-to-run-diagnostics-on-macbook-air/

Apple Diagnostics is a diagnostic tool integrated into Mac computers that enables users to identify and troubleshoot hardware issues.

Source: https://www.devicemag.com/how-to-enter-diagnostics-on-mac/

Bank of America downgraded Quest Diagnostics from a “buy” rating to a “neutral” rating and cut their price target for the company from $166.00 to $148.00 in a report on Tuesday, May 2nd.

Source: https://www.etfdailynews.com/2023/06/27/exchange-traded-concepts-llc-has-633000-holdings-in-quest-diagnostics-incorporated-nysedgx/

Creative Financial Designs Inc. ADV boosted its holdings in shares of Quest Diagnostics by 3,310.0% during the 1st quarter.

Source: https://www.dailypolitical.com/2023/10/28/fjarde-ap-fonden-fourth-swedish-national-pension-fund-has-3-66-million-position-in-quest-diagnostics-incorporated-nysedgx.html

"Diagnostics testing of the racetrack by experts have not raised concerns and the experts have concluded that the surface is consistent with prior measurements from Churchill Downs in past years," the company addded.

Source: https://www.rawstory.com/california-law-would-make-tech-giants-pay-for-news/

DnB Asset Management AS owned approximately 0.07% of Quest Diagnostics worth $11,580,000 at the end of the most recent reporting period.

Source: https://www.dailypolitical.com/2023/09/16/dnb-asset-management-as-lowers-stake-in-quest-diagnostics-incorporated-nysedgx.html

Finally, Morgan Stanley reissued an “equal weight” rating and issued a $145.00 price objective on shares of Quest Diagnostics in a research report on Thursday, August 3rd.

Source: https://www.americanbankingnews.com/2023/10/07/louisiana-state-employees-retirement-system-has-970000-stake-in-quest-diagnostics-incorporated-nysedgx.html

Foster & Motley Inc. increased its holdings in shares of Quest Diagnostics Incorporated () by 2.5% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC.

Source: https://www.etfdailynews.com/2023/11/07/foster-motley-inc-has-5-59-million-position-in-quest-diagnostics-incorporated-nysedgx/

Gestalt Diagnostics transforms pathology through an intelligent, configurable, vendor-neutral, and AI-driven digital workflow that provides true interoperability enabling pathologists to diagnose* diseases faster and more efficiently.

Source: https://www.prnewswire.com/news-releases/gestalt-takes-first-place-in-two-separate-international-ai-algorithm-challenges-301804497.html

Given the existing customer network at Fulgent Genetics and Inform Diagnostics, Fulgent Genetics can leverage the existing sales force to cross sell testing services and expand its overall customer base.

Source: https://seekingalpha.com/article/4580000-fulgent-genetics-stock-i-prefer-to-hold-for-now?source=feed_all_articles

Last year, the U.S. Department of Health and Human Services, in partnership with the Steven and Alexandra Cohen Foundation, a nonprofit to advance research of Lyme disease, initiated a competition known as the LymeX Diagnostics Prize.

Source: https://1010wcsi.com/fox-health/as-lyme-disease-tests-miss-many-acute-infections-potential-at-home-test-offers-hope-for-earlier-diagnosis/?utm_source=rss&utm_medium=rss&utm_campaign=as-lyme-disease-tests-miss-many-acute-infections-potential-at-home-test-o

Mizuho reaffirmed a “buy” rating and set a $165.00 price target on shares of Quest Diagnostics in a research report on Friday, March 17th.

Source: https://www.americanbankingnews.com/2023/04/16/australiansuper-pty-ltd-reduces-holdings-in-quest-diagnostics-incorporated-nysedgx.html

Mizuho upped their target price on Quest Diagnostics from $160.00 to $165.00 and gave the stock a “buy” rating in a report on Wednesday, December 14th.

Source: https://www.etfdailynews.com/2023/03/15/clearstead-advisors-llc-sells-1929-shares-of-quest-diagnostics-incorporated-nysedgx/

Piper Sandler increased their price target on shares of Quest Diagnostics from $130.00 to $140.00 and gave the stock a “neutral” rating in a research note on Monday, November 6th.

Source: https://www.americanbankingnews.com/2023/12/10/quest-diagnostics-incorporated-nysedgx-shares-sold-by-state-street-corp.html

Piper Sandler initiated coverage on Quest Diagnostics in a research note on Thursday, June 29th.

Source: https://www.etfdailynews.com/2023/07/09/merit-financial-group-llc-has-874000-stake-in-quest-diagnostics-incorporated-nysedgx/

Quest Diagnostics declared that its Board of Directors has approved a share repurchase program on Thursday, February 2nd that allows the company to buyback $1.00 billion in shares.

Source: https://www.etfdailynews.com/2023/04/16/quest-diagnostics-incorporated-nysedgx-stake-boosted-by-new-york-state-common-retirement-fund/

Quest Diagnostics Incorporated has a 52 week low of $120.40 and a 52 week high of $158.34.

Source: https://www.americanbankingnews.com/2023/01/22/deseret-mutual-benefit-administrators-sells-209-shares-of-quest-diagnostics-incorporated-nysedgx.html

Renaissance Technologies LLC lifted its holdings in shares of Chembio Diagnostics by 20.1% in the 4th quarter.

Source: https://www.etfdailynews.com/2023/04/22/chembio-diagnostics-inc-nasdaqcemi-major-shareholder-acquires-61650-00-in-stock/

Researchers from medtech Metabolomic Diagnostics, in collaboration with King’s College Hospital London, have which shows a 15pc increase in detection of preterm preeclampsia by using a new diagnostic method.

Source: https://www.siliconrepublic.com/innovation/cork-medtech-preeclampsia-test-metabolomic-diagnostics-research